What are the brand names for vaginal progesterone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brand Names for Vaginal Progesterone

The primary brand names for vaginal progesterone available in the United States are Crinone (progesterone gel) and Endometrin (progesterone vaginal tablets), with generic micronized progesterone capsules also widely used off-label for vaginal administration.

Available Formulations

Progesterone Gel

  • Crinone is the FDA-approved brand name for vaginal progesterone gel, available in 4% (45 mg) and 8% (90 mg) concentrations 1, 2, 3
  • The 8% gel (90 mg) is the formulation studied in clinical trials for preterm birth prevention in women with short cervix 4, 5
  • Crinone provides sustained release with once-daily administration, reducing the inconvenience compared to suppositories 2, 3

Progesterone Vaginal Tablets

  • Endometrin is the FDA-approved brand name for natural micronized progesterone vaginal tablets 6
  • This is a newer formulation that has shown similar efficacy to vaginal gel and intramuscular progesterone 6

Micronized Progesterone Capsules (Used Off-Label Vaginally)

  • Prometrium is an oral progesterone capsule (100 mg, 200 mg) that is frequently used off-label via vaginal administration 3, 7
  • Utrogestan is another brand of micronized progesterone capsules (100 mg) approved in European countries and used vaginally 8
  • Generic progesterone capsules 200 mg are also available and commonly used vaginally 7
  • The 200 mg suppository/capsule formulation has been studied in randomized trials for preterm birth prevention 4, 5

Clinical Context

For Preterm Birth Prevention

  • Both 90 mg gel (Crinone 8%) and 200 mg micronized progesterone suppositories are recommended by the American College of Obstetricians and Gynecologists for women with short cervix (≤20 mm) 5, 9
  • This use is off-label and requires patient counseling 5
  • Treatment continues from diagnosis until 36 weeks of gestation 5, 9

Patient Tolerability Differences

  • Crinone 8% gel demonstrates superior tolerability and acceptability compared to capsule formulations, with less leaking, less interference with intercourse, and easier administration 2, 8
  • Both formulations cause perineal irritation in approximately 20% of patients 2
  • Gel formulations may cause accumulation and buildup leading to irritation in some patients 6

Related Questions

Are hormone replacement therapy (HRT) sequential patches more effective than micronised progesterone and estrogen gel for managing breakthrough bleeding?
Can you be on progesterone (a hormone) therapy while still having a menstrual period?
Can you take hormone replacement therapy (HRT) with progesterone and have a progesterone-releasing intrauterine device (IUD)?
What is the management for clitoral hood swelling associated with Endometrin (progesterone) vaginal inserts?
Are Crinone (progesterone) and Endometrin (progesterone) FDA-approved for endometrial protection in postmenopausal women on Hormone Replacement Therapy (HRT)?
Is it safe to use warfarin (coumarin) in a patient with giant platelets?
What is the recommended treatment for a patient with hypercholesterolemia (elevated total cholesterol) and hyperlipidemia (elevated LDL cholesterol)?
What are the functions and locations of the Foramen of Monro, lateral ventricles, superior colliculus, and other listed brain and spinal cord structures?
What are the primary lab findings for a patient with Disseminated Intravascular Coagulation (DIC)?
Do peer-reviewed studies report hazard ratios for all-cause mortality when comparing high vs low non-aerobic physical performance (gait speed, grip strength, chair rise, balance tests, Short Physical Performance Battery (SPPB), or frailty scores) in people with obesity, and how do these compare to unfit individuals without obesity?
What are the management options for myeloproliferative neoplasms (MPNs) presenting with a diffuse macular petechial rash with central necrosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.